锦欣生殖(01951)12月10日斥资476.6万港元回购192.55万股
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan, intending to repurchase 1.9255 million shares at a cost of HKD 4.766 million [1]
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan, intending to repurchase 1.9255 million shares at a cost of HKD 4.766 million [1]